XRAY officer receives two option grants at $11.18 and $12.3

Rhea-AI Filing Summary

DENTSPLY SIRONA (XRAY) disclosed a Form 4 for an officer, SVP and Chief Supply Chain Office, reporting two stock option grants on 11/07/2025. The filings show awards of 417,200 options at an exercise price of $11.18 and 361,700 options at $12.3, each recorded as an acquisition (Code A) with $0 option price, indicating grants. Both grants are held directly and will cliff-vest on the third anniversary of the grant date (11/07/2028), with expiration on 11/07/2035. The second grant’s exercise price equals 110% of the issuer’s closing price on the grant date.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Johnson Robert Anthony

Role SVP, Chief Supply Chain Office

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	417,200	$0.00	--
Grant/Award	Stock Option (Right to Buy)	361,700	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 417,200 shares (Direct)

Footnotes (1)

1. These options will cliff-vest and become exercisable on the third anniversary of the grant date. These options will cliff-vest and become exercisable on the third anniversary of the grant date, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Robert Anthony

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28222

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Supply Chain Office

3. Date of Earliest Transaction (Month/Day/Year)
11/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$11.18	11/07/2025		A		417,200		11/07/2028(1)	11/07/2035	Common Stock	417,200	$0	417,200	D
Stock Option (Right to Buy)	$12.3	11/07/2025		A		361,700		11/07/2028(2)	11/07/2035	Common Stock	361,700	$0	361,700	D

Explanation of Responses:

1. These options will cliff-vest and become exercisable on the third anniversary of the grant date.

2. These options will cliff-vest and become exercisable on the third anniversary of the grant date, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Robert Anthony Johnson	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DENTSPLY SIRONA (XRAY) report in this Form 4?

An officer reported two stock option grants on 11/07/2025, recorded as acquisitions (Code A) at $0 option price.

How many options were granted to the XRAY officer and at what prices?

Two grants: 417,200 options at $11.18 and 361,700 options at $12.3.

When do the XRAY options vest and expire?

Both grants cliff-vest on 11/07/2028 and expire on 11/07/2035.

What is notable about the second grant’s exercise price?

It is set at 110% of the issuer’s closing price on the grant date.

What is the reporting person’s relationship to DENTSPLY SIRONA (XRAY)?

The filer is an Officer, serving as SVP, Chief Supply Chain Office.

How are the options held according to the filing?

Both grants are reported as held Direct (D).